Online citations, reference lists, and bibliographies.
← Back to Search

The Effects Of The Initial Treatment Phase And Of Adjunctive Low-dose Doxycycline Therapy On Clinical Parameters And MMP-8, MMP-9, And TIMP-1 Levels In The Saliva And Peripheral Blood Of Patients With Chronic Periodontitis

R. Górska, M. Nędzi-Góra
Published 2006 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
Abstract.IntroductionThe treatment of periodontal disease can consist of bacterial plaque reduction, risk factor elimination, and metalloproteinase inhibitor medication. The level of matrix metalloproteinases (MMPs) are regulated by endogenous tissue inhibitors of metalloproteinases (TIMPs) as well as therapeutic low-dose doxycycline. The aim of the study was to evaluate the effect of the initial phase of periodontal treatment and the effect of doxycycline on clinical parameters and the MMP-8, MMP-9, and TIMP-1 concentrations in the saliva and peripheral blood of patients with chronic periodontitis.Materials and MethodsThe study group consisted of 33 patients with chronic periodontitis. Conventional periodontal treatment (scaling and root planing) was conducted on all the patients and doxycycline (20 mg orally) was administered twice daily for three months. Thirty-three controls received the conventional treatment only. Clinical scores (PI, BI, PD, CAL) were recorded before and three months after the treatment. MMP-8, MMP-9, and TIMP-1 concentrations in saliva and peripheral blood were measured by ELISA before and after the treatment of 20 patients from the study group and 13 of the controls.ResultsThe application of doxycycline 20 mg resulted in significant improvement in clinical parameters compared with the conventional periodontal treatment. Doxycycline did not produce significant reductions in MMP-8 and MMP-9 levels in saliva observed after the conventional treatment. The study revealed increases in the TIMP-1 concentration and the MMP-8/TIMP-1 and MMP-9/TIMP-1 ratios in saliva and blood after treatment with doxycycline.ConclusionsThe study confirmed the modulating effect of doxycycline on the host response in chronic periodontitis.
This paper references
10.1111/J.1600-051X.1981.TB02024.X
Effect of nonsurgical periodontal therapy. I. Moderately advanced periodontitis.
A. Badersten (1981)
10.1111/J.1600-0765.1983.TB00388.X
Minocycline reduces gingival collagenolytic activity during diabetes. Preliminary observations and a proposed new mechanism of action.
L. Golub (1983)
10.1111/J.1600-051X.1983.TB02182.X
Comparison of surgical and nonsurgical treatment of periodontal disease. A review of current studies and additional results after 61/2 years.
B. Pihlstrom (1983)
10.1111/J.1600-051X.1984.TB01309.X
Effect of nonsurgical periodontal therapy. II. Severely advanced periodontitis.
A. Badersten (1984)
10.1111/J.1600-0765.1984.TB01334.X
Tetracyclines inhibit tissue collagenase activity. A new mechanism in the treatment of periodontal disease.
L. Golub (1984)
10.1902/jop.1985.56.11s.93
Tetracyclines Inhibit Tissue Collagenases: Effects of Ingested Low-Dose and Local Delivery Systems.
L. Golub (1985)
10.1111/J.1600-0765.1988.TB01618.X
Comparison of interstitial collagenases from human gingiva, sulcular fluid and polymorphonuclear leukocytes.
T. Sorsa (1988)
10.1111/J.1600-0765.1990.TB00914.X
Identification of polymorphonuclear leukocyte collagenase and gelatinase activities in mouthrinse samples: correlation with periodontal disease activity in adult and juvenile periodontitis.
S. Gangbar (1990)
10.1111/J.1600-0765.1990.TB01035.X
Salivary collagenase. Origin, characteristics and relationship to periodontal health.
V. Uitto (1990)
10.1111/J.1600-0765.1990.TB00923.X
Low-dose doxycycline therapy: effect on gingival and crevicular fluid collagenase activity in humans.
L. Golub (1990)
10.1177/10454411910020030201
Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs.
L. Golub (1991)
10.1111/J.1600-0765.1991.TB01649.X
The role of inflammatory mediators in the pathogenesis of periodontal disease.
R. Page (1991)
10.1128/AAC.36.1.227
Specificity of the anticollagenase action of tetracyclines: relevance to their anti-inflammatory potential.
K. Suomalainen (1992)
10.1177/10454411930040020401
Matrix metalloproteinases: a review.
H. Birkedal-Hansen (1993)
10.1111/J.1399-302X.1993.TB00578.X
Salivary collagenase, elastase- and trypsin-like proteases as biochemical markers of periodontal tissue destruction in adult and localized juvenile periodontitis.
T. Ingman (1993)
10.1902/JOP.1993.64.4.297
The effect of treatment on the activity of salivary proteases and glycosidases in adults with advanced periodontitis.
A. Nieminen (1993)
10.1902/jop.1993.64.5.474
Role of matrix metalloproteinases in human periodontal diseases.
H. Birkedal-Hansen (1993)
10.1902/jop.1993.64.8s.744
Periodontal Therapy: Prospects for the Future.
R. C. Page (1993)
10.1111/J.1600-0765.1993.TB02113.X
Role of cytokines and inflammatory mediators in tissue destruction.
H. Birkedal-Hansen (1993)
Matrix metalloproteinase: a review
H. Birkedal-Hansen (1993)
10.1177/00220345940730080201
Matrix Metalloproteinases (MMP-2 and MMP-9) of the Oral Cavity: Cellular Origin and Relationship to Periodontal Status
M. Makela (1994)
10.1111/j.1749-6632.1994.tb24729.x
Effects of Tetracyclines on Neutrophil, Gingival, and Salivary Collagenases
T. Sorsa (1994)
10.1111/J.1600-0765.1994.TB01226.X
Collagenase activity and tissue inhibitor of metalloproteinases-1 (TIMP-1) content in human whole saliva from clinically healthy and periodontally diseased subjects.
H. Hayakawa (1994)
10.1111/J.1601-0825.1996.TB00206.X
Collagenases and tissue inhibitors of metalloproteinases: a functional balance in tissue degradation.
J. Reynolds (1996)
10.1111/J.1600-051X.1996.TB00539.X
Effects of treatment on gingival crevicular collagenase, stromelysin and tissue inhibitor of metalloproteinases and their ability to predict response to treatment.
A. Haerian (1996)
10.1902/JOP.1996.67.5.506
The "cyclic" regimen of low-dose doxycycline for adult periodontitis: a preliminary study.
R. Crout (1996)
10.1902/JOP.1996.67.9.866
The effect of subgingival antimicrobial therapy on the levels of stromelysin and tissue inhibitor of metalloproteinases in gingival crevicular fluid.
N. Pourtaghi (1996)
10.1177/00220345960750080601
Human Neutrophil Gelatinase and Associated Lipocalin in Adult and Localized Juvenile Periodontitis
U. Westerlund (1996)
10.1007/s000110050193
A matrix metalloproteinase inhibitor reduces bone-type collagen degradation fragments and specific collagenases in gingival crevicular fluid during adult periodontitis
L. Golub (1997)
The functional balance of metalloproteinases and inhibitors in tissue degradation: relevance to oral pathologies.
Reynolds Jj (1997)
10.1111/j.1749-6632.1999.tb07693.x
Clinical Trials of a Matrix Metalloproteinase Inhibitor in Human Periodontal Disease
R. Ashley (1999)
10.1902/JOP.2000.71.4.521
Treatment with subantimicrobial dose doxycycline improves the efficacy of scaling and root planing in patients with adult periodontitis.
J. Caton (2000)
10.1034/J.1600-051X.2000.027005366.X
Matrix metalloproteinase-8 levels and elastase activities in gingival crevicular fluid from chronic adult periodontitis patients.
H. Chen (2000)
10.1902/ANNALS.1999.4.1.1
Development of a classification system for periodontal diseases and conditions.
G. Armitage (2000)
10.1034/J.1600-051X.2001.028002146.X
Adjunctive treatment with subantimicrobial doses of doxycycline: effects on gingival fluid collagenase activity and attachment loss in adult periodontitis.
L. Golub (2001)
10.1034/J.1600-051X.2001.280810.X
Subantimicrobial dose doxycycline as an adjunct to scaling and root planing: post-treatment effects.
J. Caton (2001)
10.1902/JOP.2002.73.5.487
Effects of phase I periodontal treatment on gingival crevicular fluid levels of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1.
G. Tüter (2002)
10.1902/JOP.2002.73.7.762
Adjunctive benefits of subantimicrobial dose doxycycline in the management of severe, generalized, chronic periodontitis.
M. J. Novak (2002)
10.1902/JOP.2004.75.1.106
The effect of adjunctive low-dose doxycycline therapy on clinical parameters and gingival crevicular fluid matrix metalloproteinase-8 levels in chronic periodontitis.
G. Emingil (2004)
Effect of subantimicrobial dosedoxycycline as an effective adjunct to scaling and root planing
Lee J.-Y (2004)
Etiopatogeneza. In Janczuk Z. (ed.): Practical Clinical Periodontology [Praktyczna periodontologia kliniczna
J. Banach (2004)
Effects of sub-antimicrobial dose doxycycline therapy on crevicular fluid MMP-8, and gingival tissue MMP-9, TIMP-1 and IL-6 levels in chronic periodontitis
최동훈 (2005)



This paper is referenced by
10.1038/s41598-021-91506-7
Systematic review and meta-analysis on the adjunctive use of host immune modulators in non-surgical periodontal treatment in healthy and systemically compromised patients
S. Corbella (2021)
10.3390/ijms21124526
The Impact of Matrix Metalloproteinase-9 on the Sequential Steps of the Metastatic Process
G. Barillari (2020)
10.35630/2199-885x/2019/9/2/160
CLINICAL AND LABORATORY EVALUATION OF THEEFFECTIVENESS OF THE APPLICATION OF NONSTEROID ANTI-INFLAMMATORY PREPARATION OF THE COXIB GROUP
Аnastasiya Gvozdeva (2019)
10.1016/j.archoralbio.2019.04.006
Histopathological and biochemical evaluation of the effect of Paeoniflorin on the periodontium during and after periodontitis formation in rats.
Sevda Kurt (2019)
10.1111/prd.12235
Periodontal complications of hyperglycemia/diabetes mellitus: Epidemiologic complexity and clinical challenge
T. Kocher (2018)
10.1002/cre2.76
Salivary MMP‐13 gender differences in periodontitis: A cross‐sectional study from Sweden
E. Virtanen (2017)
10.21608/edj.2017.76061
Evaluation of the therapeutic effect of topical calcipotriol versus topical tretinoin in treatment of oral Leukoplakia and their effect on clinical improvement and salivary level of MMP-9, IL-6 and TGF-β: A Randomized Clinical Trial
D. Ghalwash (2017)
10.1111/odi.12474
Statin intake is associated with MMP-1 level in gingival crevicular fluid of patients with periodontitis.
C. J. Poston (2016)
The Effect of Photodynamic Therapy and Diode Laser as Adjunctive Periodontal Therapy on the Inflammatory Mediators Levels in Gingival Crevicular Fluid and Clinical Periodontal Status
Faraz Teymouri (2016)
10.1007/s00784-016-1817-0
Short-term changes on C-reactive protein (CRP) levels after non-surgical periodontal treatment in systemically healthy individuals
A. B. Souza (2016)
10.14712/18059694.2016.47
Trends in Laboratory Diagnostic Methods in Periodontology.
B. Bolerázska (2016)
10.1177/1535370216638770
Detection of inflammatory biomarkers in saliva and urine: Potential in diagnosis, prevention, and treatment for chronic diseases
S. Prasad (2016)
10.3389/fcimb.2015.00065
Point-of-care diagnosis of periodontitis using saliva: technically feasible but still a challenge
S. Ji (2015)
10.1111/jre.12252
Non-surgical periodontal therapy with systemic antibiotics in patients with untreated aggressive periodontitis: a systematic review and meta-analysis.
J. A. J. Keestra (2015)
THE ROLE OF CERTAIN BIVALENT IN CHRONIC PERIODONTITIS
„GRIGORE T. POPA (2014)
10.1016/J.JDSR.2014.03.001
Current evidence and biological plausibility linking periodontitis to atherosclerotic cardiovascular disease
K. Tabeta (2014)
Oral Fluid Based Biomarkers in Periodontal Disease: Part 1. Saliva
H. AlMoharib (2014)
10.1155/2014/593151
Protein Biomarkers of Periodontitis in Saliva
J. J. Taylor (2014)
10.1902/jop.2013.134007
Evidence that periodontal treatment improves biomarkers and CVD outcomes.
F. D'Aiuto (2013)
10.5114/CEJI.2013.37746
Markers of inflammation in periodontal diseases
M. Nędzi-Góra (2013)
10.1111/jcpe.12061
Evidence that periodontal treatment improves biomarkers and CVD outcomes.
F. D'Aiuto (2013)
The effect of adjunctive low-dose doxycycline and licorice therapy on gingival crevicular fluid matrix metalloproteinase-8 levels in chronic periodontitis
Shirin Farhad (2013)
O UsO DA DOXICICLINA EM DOsE sUBANTIMICROBIANA EM PACIENTEs COM DOENÇA PERIODONTAL: UMA REVIsÃO DE LITERATURA The use of subantimicrobial dose doxycycline in patients with periodontal disease: a review
Marcelo Cavalcante Marinho (2013)
10.1016/j.cca.2013.03.008
Salivary MMPs, TIMPs, and MPO levels in periodontal disease patients and controls.
C. A. Meschiari (2013)
Salivary proteins as biomarkers for periodontal disease.
J. Franco (2012)
10.11606/T.58.2012.TDE-23052012-161622
Biomarcadores diagnósticos relacionados à atividade da doença periodontal em diabéticos
P. Costa (2012)
EVALUATION OF THE IMMUNOMODULATORY EFFECT OF GENERAL TREATMENT WITH SUB-ANTIMICROBIAL DOSES OF DOXYCYCLINE IN CHRONIC EXPERIMENTAL-INDUCED PERIODONTITIS
Adina Bianca Bo şca (2012)
10.1016/j.phrs.2010.12.003
Clinical studies on the management of periodontal diseases utilizing subantimicrobial dose doxycycline (SDD).
J. Caton (2011)
10.1007/s10517-011-1498-2
Content of Matrix Metalloproteinase-8 and Matrix Metalloproteinase-9 in Oral Fluid of Patients with Chronic Generalized Periodontitis
N. Kushlinskii (2011)
10.1016/j.archoralbio.2010.10.021
Salivary levels of matrix metalloproteinase (MMP)-9 and tissue inhibitor of matrix metalloproteinase (TIMP)-1: a pilot study about the relationship with periodontal status and MMP-9(-1562C/T) gene promoter polymorphism.
D. M. Isaza-Guzmán (2011)
10.1902/jop.2011.110026
Long-term efficacy of subantimicrobial-dose doxycycline as an adjunctive treatment to scaling and root planing: a systematic review and meta-analysis.
F. Sgolastra (2011)
10.1111/j.1600-051X.2011.01706.x
Salivary biomarkers of periodontal disease in response to treatment.
William M Sexton (2011)
See more
Semantic Scholar Logo Some data provided by SemanticScholar